Anti-C1Q Ab, IgG (RDL)

Optimal result: 0 – 20 Units

Elevated levels of Anti-C1Q antibodies, specifically IgG, can be associated with various autoimmune diseases, particularly lupus nephritis, a kidney disorder linked to systemic lupus erythematosus (SLE). This test is valuable in diagnosing and monitoring autoimmune diseases, especially those affecting the kidneys.

A positive result for Anti-C1Q Ab, IgG may suggest an increased risk of renal flares in individuals with lupus nephritis. Serial testing can show changes in antibody levels, providing insights into the progression or management of the disease.

Serial testing shows that increasing amounts of IgG anti-C1q predict renal flares in SLE patients. Elevated serum titers of anti-C1q antibodies tend to be associated with proliferative forms of lupus, glomerulonephritis and subendothelial deposits of immune complexes.

The Anti-C1Q Ab, IgG (RDL) test measures the levels of IgG antibodies against C1q in a patient's blood.

What is C1q?

C1q is a protein that plays a crucial role in the complement system, which is a part of the immune system responsible for recognizing and clearing pathogens and damaged cells from the body.

Patients with suspected autoimmune conditions, particularly lupus nephritis, may undergo this test as part of their diagnostic workup. 

Systemic lupus erythematosus (SLE) is an autoimmune disease with multiorgan involvement. Approximately 37-45% of patients with SLE will develop lupus nephritis, which negatively impacts patient survival. Testing for C1q antibodies assists in evaluating the risk of lupus nephritis development.

 

Limitations:

- Not all patients with lupus nephritis will be positive for C1q antibodies

- The presence of C1q antibodies is not specific for SLE

Anti-C1Q Ab, IgG (RDL)
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Anti-C1Q Ab, IgG (RDL) — 10,000+ markers explained
One Anti-C1Q Ab, IgG (RDL) result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro